GlassScriptPhysician profile
David A Sandler
NPI 1619947124
$85,796.46
in general payments reported to CMS, 2019-2025
23 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $12K · 2021: $8,267 · 2022: $5,187 · 2023: $4,256 · 2024: $1,634 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,193 · Consulting Fee: $3,000 · Travel and Lodging: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,156.25 |
| Food and Beverage | $5,192.54 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $1,918.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $34,948.85 | 2019-2025 | General - Ep, Watchman Flx, Watchman Access System |
| Pfizer INC. | $21,898.51 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $10,766.27 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $7,616.95 | 2019-2025 | Eliquis, Camzyos |
| Biosense Webster, INC. | $2,549.73 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $2,493.09 | 2019-2025 | Aveir, Ensite, Quartet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,422.90 | 2019-2022 | |
| Medical Device Business Services, INC. | $767.45 | 2019 | |
| Medtronic, INC. | $637.25 | 2021-2025 | Micra, Affera Mapping System, Selectsecure |
| Zoll Respicardia, INC. | $386.06 | 2019-2021 | |
| Atricure, INC. | $349.92 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $335.23 | 2024-2025 | Impella |
| Philips North America LLC | $235.80 | 2019-2025 | Mcot, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $97.28 | 2022-2025 | |
| Cardiva Medical, INC. | $74.55 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $73.72 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $34.64 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $29.27 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $28.99 | 2022 | |
| Baxter Healthcare | $18.96 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $16.95 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.09 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.